Glen Poisson, MD, MBA, Cmc
About Glen Poisson, MD, MBA, Cmc
Glen Poisson, MD, MBA, Cmc, is a Pharmacovigilance Physician with extensive experience in safety science and risk management. He currently serves as Director of Safety Science at a confidential organization and has held various roles in pharmacovigilance since 2015.
Work at Confidential
Glen Poisson has been serving as the Director of Safety Science at Confidential since 2021. In this role, he oversees pharmacovigilance activities, ensuring compliance with safety regulations and standards. He has also worked as a Pharmacovigilance Physician at Confidential since 2018, where he applies his expertise in safety data management and adverse event reporting.
Previous Experience in Pharmacovigilance
Prior to his current roles, Glen Poisson worked at Novocure as the US Medical Safety Manager from 2018 to 2020. His responsibilities included managing safety data and evaluating adverse events. He also held the position of Manager of Safety Evaluation Risk Management at Seagen for 11 months in 2020-2021, focusing on risk management strategies.
Education and Expertise
Glen Poisson holds an MD and an MBA, along with certification as a MedDRA Coder. His educational background supports his proficiency in pharmacovigilance, particularly in evaluating medication guides and safety data. He is skilled in using the ARGUS safety database for managing safety data effectively.
Pharmacovigilance Skills
Glen Poisson has extensive experience in generating narratives and conducting follow-ups with clinical sites and reporters regarding adverse event (AE) and serious adverse event (SAE) reports. His expertise includes assessing reportability, seriousness, expectedness, and causality of adverse events, ensuring accurate safety evaluations.
Contributions to Industry Standards
As a certified MedDRA Coder, Glen Poisson contributes to the ICH MedDRA Management Board. His involvement in this board highlights his commitment to maintaining high standards in medical terminology and pharmacovigilance practices.